{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:32:30Z","timestamp":1777383150812,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR40142\/ BTIS\/137\/72\/2023"],"award-info":[{"award-number":["BT\/PR40142\/ BTIS\/137\/72\/2023"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00284-026-04834-0","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:16:10Z","timestamp":1774984570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Resistance Vulnerabilities of Clinical ESKAPE Isolates Using Lactoferrin and Its Functional Fragments"],"prefix":"10.1007","volume":"83","author":[{"given":"Surabhi","family":"Pandit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarita","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tej P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"10325","key":"4834_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/s0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, Ikuta KS, Sharara F et al (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399(10325):629\u2013655. https:\/\/doi.org\/10.1016\/s0140-6736(21)02724-0","journal-title":"Lancet"},{"key":"4834_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10338-8","author":"SE Wp","year":"2025","unstructured":"Wp SE, Norhidayah M, Ar MNA (2025) Factors associated with multidrug-resistant organism (MDRO) mortality: an analysis from the national surveillance of multidrug-resistant organism, 2018-2022. BMC Infect Dis. https:\/\/doi.org\/10.1186\/s12879-024-10338-8","journal-title":"BMC Infect Dis"},{"issue":"4","key":"4834_CR3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01735-20","volume":"65","author":"J Camp","year":"2021","unstructured":"Camp J, Schuster S, Vavra M et al (2021) Limited multidrug resistance efflux pump overexpression among multidrug-resistant Escherichia coli strains of ST131. Antimicrob Agents Chemother 65(4):e01735-20. https:\/\/doi.org\/10.1128\/AAC.01735-20","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"4834_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00710-21","volume":"65","author":"M Choquet","year":"2021","unstructured":"Choquet M, Lohou E, Pair E, Sonnet P, Mulli\u00e9 C (2021) Efflux pump overexpression profiling in Acinetobacter baumannii and study of new 1-(1-Naphthylmethyl)-Piperazine analogs as potential efflux inhibitors. Antimicrob Agents Chemother 65(9):e00710-21. https:\/\/doi.org\/10.1128\/AAC.00710-21","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"4834_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ja.2015.34","volume":"68","author":"K Shigemura","year":"2015","unstructured":"Shigemura K, Osawa K, Kato A et al (2015) Association of overexpression of efflux pump genes with antibiotic resistance in Pseudomonas aeruginosa strains clinically isolated from urinary tract infection patients. J Antibiot 68(9):568\u2013572. https:\/\/doi.org\/10.1038\/ja.2015.34","journal-title":"J Antibiot"},{"issue":"3","key":"4834_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2025.116804","volume":"112","author":"S Maraki","year":"2025","unstructured":"Maraki S, Mavromanolaki VE, Kasimati A, Iliaki-Giannakoudaki E, Stafylaki D (2025) The evolving epidemiology of antimicrobial resistance of ESKAPE pathogens isolated in the intensive care unit of a Greek university hospital. Diagn Microbiol Infect Dis 112(3):116804. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116804","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10474","key":"4834_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0140-6736(24)02081-6","volume":"405","author":"N Macesic","year":"2025","unstructured":"Macesic N, Uhlemann AC, Peleg AY (2025) Multidrug-resistant Gram-negative bacterial infections. Lancet 405(10474):257\u2013272. https:\/\/doi.org\/10.1016\/S0140-6736(24)02081-6","journal-title":"Lancet"},{"key":"4834_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(25)00118-5","author":"H Sati","year":"2025","unstructured":"Sati H, Carrara E, Savoldi A et al (2025) The WHO bacterial priority pathogens list 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/s1473-3099(25)00118-5","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"4834_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41564-024-01891-8","volume":"10","author":"L Daruka","year":"2025","unstructured":"Daruka L, Czikkely MS, Szili P et al (2025) ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro. Nat Microbiol 10(2):313\u2013331. https:\/\/doi.org\/10.1038\/s41564-024-01891-8","journal-title":"Nat Microbiol"},{"issue":"3","key":"4834_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.mayocp.2020.10.033","volume":"96","author":"AM Mohareb","year":"2021","unstructured":"Mohareb AM, Letourneau AR, S\u00e1nchez SM, Walensky RP, Hyle EP (2021) Addressing antibiotic overuse in the outpatient setting: lessons from behavioral economics. Mayo Clin Proc 96(3):537\u2013542. https:\/\/doi.org\/10.1016\/j.mayocp.2020.10.033","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"4834_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.bbagen.2011.06.018","volume":"1820","author":"IA Garc\u00eda-Montoya","year":"2012","unstructured":"Garc\u00eda-Montoya IA, Cend\u00f3n TS, Ar\u00e9valo-Gallegos S, Rasc\u00f3n-Cruz Q (2012) Lactoferrin a multiple bioactive protein: an overview. Biochimica et Biophysica Acta (BBA) - General Subjects 1820(3):226\u2013236. https:\/\/doi.org\/10.1016\/j.bbagen.2011.06.018","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"issue":"4","key":"4834_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/ph9040061","volume":"9","author":"F Giansanti","year":"2016","unstructured":"Giansanti F, Panella G, Leboffe L, Antonini G (2016) Lactoferrin from milk: nutraceutical and pharmacological properties. Pharmaceuticals Basel 9(4):61\u201361. https:\/\/doi.org\/10.3390\/ph9040061","journal-title":"Pharmaceuticals Basel"},{"issue":"12","key":"4834_CR13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/nure.12155","volume":"72","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Lima CF, Rodrigues LR (2014) Anticancer effects of lactoferrin: underlying mechanisms and future trends in cancer therapy. Nutr Rev 72(12):763\u2013773. https:\/\/doi.org\/10.1111\/nure.12155","journal-title":"Nutr Rev"},{"key":"4834_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01438","volume":"8","author":"ML Kruzel","year":"2017","unstructured":"Kruzel ML, Zimecki M, Actor JK (2017) Lactoferrin in a context of inflammation-induced pathology. Front Immunol 8:1438. https:\/\/doi.org\/10.3389\/fimmu.2017.01438","journal-title":"Front Immunol"},{"issue":"9","key":"4834_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091985","volume":"18","author":"L Rosa","year":"2017","unstructured":"Rosa L, Cutone A, Lepanto M, Paesano R, Valenti P (2017) Lactoferrin: a natural glycoprotein involved in iron and inflammatory homeostasis. Int J Mol Sci 18(9):1985. https:\/\/doi.org\/10.3390\/ijms18091985","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4834_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/aps.2013.200","volume":"35","author":"T Siqueiros-Cend\u00f3n","year":"2014","unstructured":"Siqueiros-Cend\u00f3n T, Ar\u00e9valo-Gallegos S, Iglesias-Figueroa BF, Garc\u00eda-Montoya IA, Salazar-Mart\u00ednez J, Rasc\u00f3n-Cruz Q (2014) Immunomodulatory effects of lactoferrin. Acta Pharmacol Sin 35(5):557\u2013566. https:\/\/doi.org\/10.1038\/aps.2013.200","journal-title":"Acta Pharmacol Sin"},{"issue":"1-2","key":"4834_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/0167-4838(92)90346-F","volume":"1121","author":"W Bellamy","year":"1992","unstructured":"Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M (1992) Identification of the bactericidal domain of Lactoferrin. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1121(1\u20132):130\u2013136. https:\/\/doi.org\/10.1016\/0167-4838(92)90346-F","journal-title":"Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology"},{"issue":"9","key":"4834_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","volume":"20","author":"MC Fisher","year":"2022","unstructured":"Fisher MC, Alastruey-Izquierdo A, Berman J et al (2022) Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol 20(9):557\u2013571. https:\/\/doi.org\/10.1038\/s41579-022-00720-1","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"4834_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092562","volume":"12","author":"F Superti","year":"2020","unstructured":"Superti F (2020) Lactoferrin from bovine milk: a protective companion for life. Nutrients 12(9):2562. https:\/\/doi.org\/10.3390\/nu12092562","journal-title":"Nutrients"},{"issue":"10","key":"4834_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1080\/17460913.2024.2352263","volume":"19","author":"S Pandit","year":"2024","unstructured":"Pandit S, Singh A, Singh J et al (2024) Synergistic action of lactoferrin and its derived functional fragments as a promising therapeutic agent in combating mucormycosis. Future Microbiol 19(10):857\u2013866. https:\/\/doi.org\/10.1080\/17460913.2024.2352263","journal-title":"Future Microbiol"},{"issue":"7","key":"4834_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/pr8070804","volume":"8","author":"BB Matija\u0161i\u0107","year":"2020","unstructured":"Matija\u0161i\u0107 BB, Ober\u010dkal J, Mohar Lorbeg P et al (2020) Characterisation of lactoferrin isolated from acid whey using pilot-scale monolithic ion-exchange chromatography. Processes 8(7):804. https:\/\/doi.org\/10.3390\/pr8070804","journal-title":"Processes"},{"issue":"8","key":"4834_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0273088","volume":"17","author":"JR Hussan","year":"2022","unstructured":"Hussan JR, Irwin SG, Mathews B, Swift S, Williams DL, Cornish J (2022) Optimal dose of Lactoferrin reduces the resilience of in vitro Staphylococcus aureus colonies. PLoS ONE 17(8):e0273088. https:\/\/doi.org\/10.1371\/journal.pone.0273088","journal-title":"PLoS ONE"},{"issue":"2","key":"4834_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10020165","volume":"10","author":"B Kowalska-Krochmal","year":"2021","unstructured":"Kowalska-Krochmal B, Dudek-Wicher R (2021) The minimum inhibitory concentration of antibiotics: methods, interpretation, clinical relevance. Pathogens 10(2):165. https:\/\/doi.org\/10.3390\/pathogens10020165","journal-title":"Pathogens"},{"issue":"3","key":"4834_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"4834_CR25","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s10096-019-03673-1","volume":"38","author":"F Hu","year":"2019","unstructured":"on behalf of the China Antimicrobial Surveillance Network (CHINET) Study Group, Hu F, Guo Y et al (2019) Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis 38(12):2275\u20132281. https:\/\/doi.org\/10.1007\/s10096-019-03673-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"4834_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1365-2672.1992.tb05007.x","volume":"73","author":"W Bellamy","year":"1992","unstructured":"Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M (1992) Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N \u2010terminal region of bovine lactoferrin. J Appl Bacteriol 73(6):472\u2013479. https:\/\/doi.org\/10.1111\/j.1365-2672.1992.tb05007.x","journal-title":"J Appl Bacteriol"},{"issue":"1","key":"4834_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-bioeng-010220-095711","volume":"23","author":"M Lei","year":"2021","unstructured":"Lei M, Jayaraman A, Van Deventer JA, Lee K (2021) Engineering selectively targeting antimicrobial peptides. Annu Rev Biomed Eng 23(1):339\u2013357. https:\/\/doi.org\/10.1146\/annurev-bioeng-010220-095711","journal-title":"Annu Rev Biomed Eng"},{"key":"4834_CR28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.72850","volume":"11","author":"EF Semeraro","year":"2022","unstructured":"Semeraro EF, Marx L, Mandl J et al (2022) Lactoferricins impair the cytosolic membrane of Escherichia coli within a few seconds and accumulate inside the cell. Elife 11:e72850. https:\/\/doi.org\/10.7554\/eLife.72850","journal-title":"Elife"},{"issue":"6","key":"4834_CR29","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1128\/iai.62.6.2628-2632.1994","volume":"62","author":"BJ Appelmelk","year":"1994","unstructured":"Appelmelk BJ, An YQ, Geerts M et al (1994) Lactoferrin is a lipid A-binding protein. Infect Immun 62(6):2628\u20132632. https:\/\/doi.org\/10.1128\/iai.62.6.2628-2632.1994","journal-title":"Infect Immun"},{"issue":"1","key":"4834_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4265\/bio.13.29","volume":"13","author":"H Wakabayashi","year":"2008","unstructured":"Wakabayashi H, Yamauchi K, Takase M (2008) Inhibitory effects of bovine lactoferrin and Lactoferricin B on Enterobacter sakazakii. Biocontrol Sci 13(1):29\u201332. https:\/\/doi.org\/10.4265\/bio.13.29","journal-title":"Biocontrol Sci"},{"key":"4834_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02386","volume":"10","author":"UA Angulo-Zamudio","year":"2019","unstructured":"Angulo-Zamudio UA, Vidal JE, Nazmi K et al (2019) Lactoferrin disaggregates pneumococcal biofilms and inhibits acquisition of resistance through its DNase activity. Front Microbiol 10:2386. https:\/\/doi.org\/10.3389\/fmicb.2019.02386","journal-title":"Front Microbiol"},{"key":"4834_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2020.102301","volume":"67","author":"SN Wuersching","year":"2021","unstructured":"Wuersching SN, Huth KC, Hickel R, Kollmuss M (2021) Inhibitory effect of LL-37 and human lactoferricin on growth and biofilm formation of anaerobes associated with oral diseases. Anaerobe 67:102301. https:\/\/doi.org\/10.1016\/j.anaerobe.2020.102301","journal-title":"Anaerobe"},{"issue":"1","key":"4834_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-015-0473-x","volume":"15","author":"S S\u00e1nchez-G\u00f3mez","year":"2015","unstructured":"S\u00e1nchez-G\u00f3mez S, Ferrer-Espada R, Stewart PS, Pitts B, Lohner K, Mart\u00ednez De Tejada G (2015) Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human Lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms. BMC Microbiol 15(1):137. https:\/\/doi.org\/10.1186\/s12866-015-0473-x","journal-title":"BMC Microbiol"},{"issue":"1","key":"4834_CR34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1139\/bcb-2020-0253","volume":"99","author":"G Ramamourthy","year":"2021","unstructured":"Ramamourthy G, Vogel HJ (2021) Antibiofilm activity of lactoferrin-derived synthetic peptides against Pseudomonas aeruginosa PAO1. Biochem Cell Biol 99(1):138\u2013148. https:\/\/doi.org\/10.1139\/bcb-2020-0253","journal-title":"Biochem Cell Biol"},{"key":"4834_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00329","volume":"9","author":"SC Vega","year":"2018","unstructured":"Vega SC, Mart\u00ednez DA, Chal\u00e1 MDS, Vargas HA, Rosas JE (2018) Design, synthesis and evaluation of branched RRWQWR-based peptides as antibacterial agents against clinically relevant Gram-Positive and Gram-Negative pathogens. Front Microbiol 9:329. https:\/\/doi.org\/10.3389\/fmicb.2018.00329","journal-title":"Front Microbiol"},{"issue":"10","key":"4834_CR36","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s10096-017-2987-7","volume":"36","author":"P Morici","year":"2017","unstructured":"Morici P, Florio W, Rizzato C et al (2017) Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains. Eur J Clin Microbiol Infect Dis 36(10):1739\u20131748. https:\/\/doi.org\/10.1007\/s10096-017-2987-7","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4834_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"MS Mulani","year":"2019","unstructured":"Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR (2019) Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol 10:539. https:\/\/doi.org\/10.3389\/fmicb.2019.00539","journal-title":"Front Microbiol"},{"issue":"11","key":"4834_CR38","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/microorganisms8111716","volume":"8","author":"FF Andrade","year":"2020","unstructured":"Andrade FF, Silva D, Rodrigues A, Pina-Vaz C (2020) Colistin update on its mechanism of action and resistance, present and future challenges. Microorganisms 8(11):1716. https:\/\/doi.org\/10.3390\/microorganisms8111716","journal-title":"Microorganisms"},{"issue":"1","key":"4834_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/antibiotics11010002","volume":"11","author":"P Sangthawan","year":"2021","unstructured":"Sangthawan P, Geater AF, Naorungroj S, Nikomrat P, Nwabor OF, Chusri S (2021) Characteristics, influencing factors, predictive scoring system, and outcomes of the patients with nephrotoxicity associated with administration of intravenous colistin. Antibiotics 11(1):2. https:\/\/doi.org\/10.3390\/antibiotics11010002","journal-title":"Antibiotics"},{"issue":"6","key":"4834_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4103\/ijccm.IJCCM_140_17","volume":"21","author":"A Ghafur","year":"2017","unstructured":"Ghafur A, Gohel S, Raja T et al (2017) Colistin nephrotoxicity in adults: single centre large series from India. Indian J Crit Care Med 21(6):350\u2013354. https:\/\/doi.org\/10.4103\/ijccm.IJCCM_140_17","journal-title":"Indian J Crit Care Med"},{"issue":"5","key":"4834_CR41","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.mjafi.2023.06.006","volume":"79","author":"B Prava Rout","year":"2023","unstructured":"Prava Rout B, Behera B, Kumar Sahu K, Praharaj I, Otta S (2023) An overview of colistin resistance: a breach in last line defense. Med J Armed Forces India 79(5):516\u2013525. https:\/\/doi.org\/10.1016\/j.mjafi.2023.06.006","journal-title":"Med J Armed Forces India"},{"issue":"5","key":"4834_CR42","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/pharmaceutics12050434","volume":"12","author":"YH Hsu","year":"2020","unstructured":"Hsu YH, Chiu IJ, Lin YF, Chen YJ, Lee YH, Chiu HW (2020) Lactoferrin contributes a renoprotective effect in acute kidney injury and early renal fibrosis. Pharmaceutics 12(5):434. https:\/\/doi.org\/10.3390\/pharmaceutics12050434","journal-title":"Pharmaceutics"},{"issue":"3","key":"4834_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151486","volume":"11","author":"R Hegazy","year":"2016","unstructured":"Hegazy R, Salama A, Mansour D, Hassan A (2016) Renoprotective effect of lactoferrin against chromium-induced acute kidney injury in rats: Involvement of IL-18 and IGF-1 inhibition. PLoS ONE 11(3):e0151486. https:\/\/doi.org\/10.1371\/journal.pone.0151486","journal-title":"PLoS ONE"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04834-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-04834-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04834-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:25:40Z","timestamp":1777368340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-04834-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4834"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-04834-0","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"272"}}